Avtor/Urednik		Dhillon, Sharonjit K.; Oštrbenk Valenčak, Anja; Xu, Lan; Poljak, Mario; Arbyna, Marc
Naslov		Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
Tip		članek
Vol. in št.		Letnik 59, št. 6
Leto izdaje		2021
Obseg		str. 1-9
ISSN		1098-660X - Journal of clinical microbiology
Jezik		eng
Abstrakt		Only clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the recently launched Abbott Alinity m HR HPV assay (Alinity m) to detect cervical precancerous lesions was assessed against the standard comparator test (Hybrid Capture 2; HC2) and against two previously validated alternative comparator tests (Abbott RealTime HR HPV and Roche cobas 4800 assays). Validation was conducted using 1,300 consecutive cervical samples from women attending an organized population-based cervical screening program enriched with 300 cytologically abnormal samples. Overall high-risk HPV test concordance was assessed by kappa values; the concordance for HPV-16 and HPV-18 was assessed for Alinity m, RealTime, and cobas, and the Linear Array (Roche) was used for more detailed genotyping concordance. In the total study population, the relative sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and CIN3+ of Alinity m compared to HC2 was 1.02 (95% confidence interval [CI], 0.99 to 1.06) and 1.03 (95% CI, 0.99 to 1.06), respectively. The relative specificity for nondiseased subjects (rCIN1) was 1.01 (95% CI, 1.00 to 1.02) (all p non-inferiority r 0.001). Alinity m showed noninferior clinical accuracy among women 30 years or older when cobas or RealTime was used as a comparator. HPV genotype-specific concordance between Alinity m and the three comparator tests showed excellent agreement, with kappa values ranging from 0.82 to 1.00. In conclusion, Alinity m fulfills the international accuracy requirements for use in cervical cancer screening and shows excellent HPV genotype-specific concordance with three clinically validated HPV tests.
Proste vsebinske oznake		HPV genotyping cervical cancer VALGENT genotipizacija HPV rak materničnega vratu VALGENT